<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The frequency and significance of hepatic lymph node (HLN) <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> were retrospectively evaluated in 43 patients with unresectable synchronous <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastasis</z:e> of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> who underwent resection of the <z:e sem="disease" ids="C0677930" disease_type="Neoplastic Process" abbrv="">primary tumor</z:e> and histopathologic evaluation of HLNs between March 1997 and August 2007 </plain></SENT>
<SENT sid="1" pm="."><plain>HLN <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> was detected in 12 patients (27.9%) </plain></SENT>
<SENT sid="2" pm="."><plain>No significant correlations were observed between the presence of HLN <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> and any of the 12 clinicopathologic factors examined </plain></SENT>
<SENT sid="3" pm="."><plain>On multivariate analysis using the Cox proportional hazards model, the presence of HLN <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> (P = 0.002), along with a large number (&gt; or = 4) of regional <z:e sem="disease" ids="C0686619" disease_type="Neoplastic Process" abbrv="">lymph node metastases</z:e> (P = 0.003), and nonuse of <z:chebi fb="0" ids="31941">oxaliplatin</z:chebi>-based chemotherapy (P = 0.005) were identified as independent risk factors for shorter survival </plain></SENT>
<SENT sid="4" pm="."><plain>To establish a new therapeutic strategy for initially unresectable <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastasis</z:e> of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e>, HLNs should be examined histologically in patients undergoing resection of hepatic lesions when they are rendered resectable by effective chemotherapy </plain></SENT>
</text></document>